BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23077976)

  • 1. A new amphipathic, amino-acid-pairing (AAP) peptide as siRNA delivery carrier: physicochemical characterization and in vitro uptake.
    Jafari M; Xu W; Naahidi S; Chen B; Chen P
    J Phys Chem B; 2012 Nov; 116(44):13183-91. PubMed ID: 23077976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of a designed amphipathic cell-penetrating peptide and its effect on solubility, secondary structure, and uptake efficiency.
    Jafari M; Karunaratne DN; Sweeting CM; Chen P
    Biochemistry; 2013 May; 52(20):3428-35. PubMed ID: 23614788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and characterization of a new peptide vector for short interfering RNA delivery.
    Chen B; Xu W; Pan R; Chen P
    J Nanobiotechnology; 2015 Jun; 13():39. PubMed ID: 26054932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and evaluation of a peptide-based siRNA delivery system in vitro.
    Chen B; Yoo K; Xu W; Pan R; Han XX; Chen P
    Drug Deliv Transl Res; 2017 Aug; 7(4):507-515. PubMed ID: 28349343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and evaluation of endosomolytic biocompatible peptides as carriers for siRNA delivery.
    Xu W; Pan R; Zhao D; Chu D; Wu Y; Wang R; Chen B; Ding Y; Sadatmousavi P; Yuan Y; Chen P
    Mol Pharm; 2015 Jan; 12(1):56-65. PubMed ID: 25378277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy.
    Mo RH; Zaro JL; Shen WC
    Mol Pharm; 2012 Feb; 9(2):299-309. PubMed ID: 22171592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicochemical characterization of siRNA-peptide complexes.
    Law M; Jafari M; Chen P
    Biotechnol Prog; 2008; 24(4):957-63. PubMed ID: 19194904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insight into the role of physicochemical parameters in a novel series of amphipathic peptides for efficient DNA delivery.
    Sharma R; Shivpuri S; Anand A; Kulshreshtha A; Ganguli M
    Mol Pharm; 2013 Jul; 10(7):2588-600. PubMed ID: 23725377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A non-covalent peptide-based strategy for siRNA delivery.
    Crombez L; Divita G
    Methods Mol Biol; 2011; 683():349-60. PubMed ID: 21053142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum stability and physicochemical characterization of a novel amphipathic peptide C6M1 for siRNA delivery.
    Jafari M; Xu W; Pan R; Sweeting CM; Karunaratne DN; Chen P
    PLoS One; 2014; 9(5):e97797. PubMed ID: 24831131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonviral pulmonary delivery of siRNA.
    Merkel OM; Kissel T
    Acc Chem Res; 2012 Jul; 45(7):961-70. PubMed ID: 21905687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
    Kim HK; Davaa E; Myung CS; Park JS
    Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoplasm-responsive nanocarriers conjugated with a functional cell-penetrating peptide for systemic siRNA delivery.
    Tanaka K; Kanazawa T; Horiuchi S; Ando T; Sugawara K; Takashima Y; Seta Y; Okada H
    Int J Pharm; 2013 Oct; 455(1-2):40-7. PubMed ID: 23911914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG-PCL nanomicelles.
    Kanazawa T; Sugawara K; Tanaka K; Horiuchi S; Takashima Y; Okada H
    Eur J Pharm Biopharm; 2012 Aug; 81(3):470-7. PubMed ID: 22579732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
    Wang XL; Xu R; Lu ZR
    J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel cell-penetrating peptide TAT-A1 delivers siRNA into tumor cells selectively.
    Fang B; Jiang L; Zhang M; Ren FZ
    Biochimie; 2013 Feb; 95(2):251-7. PubMed ID: 23009929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. siRNA delivery: from lipids to cell-penetrating peptides and their mimics.
    Gooding M; Browne LP; Quinteiro FM; Selwood DL
    Chem Biol Drug Des; 2012 Dec; 80(6):787-809. PubMed ID: 22974319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six-cell penetrating peptide-based fusion proteins for siRNA delivery.
    Li H; Tsui T
    Drug Deliv; 2015 May; 22(3):436-43. PubMed ID: 24491156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct translocation as major cellular uptake for CADY self-assembling peptide-based nanoparticles.
    Rydström A; Deshayes S; Konate K; Crombez L; Padari K; Boukhaddaoui H; Aldrian G; Pooga M; Divita G
    PLoS One; 2011; 6(10):e25924. PubMed ID: 21998722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. siRNA delivery using amphipathic cell-penetrating peptides into human hepatoma cells.
    Furukawa K; Tanaka M; Oba M
    Bioorg Med Chem; 2020 Apr; 28(8):115402. PubMed ID: 32146061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.